Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

The following is a summary of “2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and ...

ACR's full guidelines on screening, treatment and management of #lupusnephritis are now available and emphasize continuous ...

Lupus nephritis frequently recurs in the transplanted kidney, sometimes without clinical signs. Lupus nephritis frequently recurs after kidney transplantation, and it may be clinically quiescent ...

Treating lupus nephritis to achieve sustained remission for at least 3 years likely protects kidney function. In patients with active lupus nephritis, at least 3 years of sustained clinical ...

Therapy should include either belimumab or a calcineurin inhibitor, plus one or more conventional medications such as corticosteroids, cyclophosphamide, and/or a mycophenolic acid analog (e.g., ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

At univariable analysis, both anti-C1q antibodies and non-use of hydroxychloroquine predicted renal flares at baseline and 6 and 12 months. Proteinuria (24/h proteinuria and proteinuria 0.5 g/day or ...

The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...

DelveInsight's "LUPKYNIS Market Size, Forecast, and Market Insight Report" highlights the details around LUPKYNIS, the first ...

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in ...